Stuart Essig

Dr. Stuart M.
Essig is an Independent Director at Piper Sandler Cos., a Chairman at Mission Bio, Inc., an Independent Director at IDEXX Laboratories, Inc., a Venture Partner at Wellington Partners Advisory AG, a Venture Partner at Wellington Partners GmbH, a Managing Director at Prettybrook Partners LLC, a Chairman, President & Chief Executive Officer at Integra LifeSciences Holdings Corp., a Member-Managers Board at Availity LLC and a President & Chief Executive Officer at Integra CI, Inc. He is on the Board of Directors at Piper Sandler Cos., IDEXX Laboratories, Inc., Breg, Inc. and Isles, Inc. Dr. Essig was previously employed as an Independent Director by Orthofix Medical, Inc., a Lead Independent Director by SeaSpine Holdings Corp., an Independent Director by Owens & Minor, Inc., an Independent Director by St. Jude Medical LLC, a Managing Director-Medical Technology Practice by Goldman Sachs & Co., and a Treasurer & Director by Advanced Medical Technology Association.
He also served on the board at Zimmer Holdings, Inc., St. Jude Medical, Inc. and Vital Signs, Inc. He received his undergraduate degree from Woodrow Wilson School of Public & International Affairs, an MBA from The University of Chicago Booth School of Business and a doctorate degree from The University of Chicago Booth School of Business.